#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Rheumatoid arthritis Hereditary hypophosphataemic rickets Microvillous inclusion disease Langerhans' cell histiocytosis Retinal dystrophy Hepatocellular carcinoma Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Synovial sarcoma recurrent Autoimmune disorder Malignant oligodendroglioma Meningitis meningococcal Hypotransferrinaemia Astrocytoma malignant Follicular lymphoma Insulinoma More trials…

    Learn about Rare Diseases

    Hairy cell leukaemia recurrent Waldenstrom’s macroglobulinaemia recurrent – Diagnostics Extranodal marginal zone B-cell lymphoma (MALT type) – Treatment Hereditary angioedema with C1 esterase inhibitor deficiency Lymphangioma – Treatment Primary immunodeficiency syndrome – Life with Disease SAPHO syndrome – Trials in Disease Paroxysmal nocturnal haemoglobinuria – Diagnostics Alport’s syndrome – Life with Disease Combined immunodeficiency – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Elezanumab Eik1003 Holcus Lanatus Pollen Extract Prucalopride Hydrochlorothiazide Sodium S-Lactate Solution Dried Ferrous Sulfate Bi 3720931 CHOLINE ALFOSCERATE Tozorakimab EGANELISIB Regorafenib Glucagon Tinzaparin Mirikizumab Sacituzumab Govitecan Blinatumomab METHYLPHENIDATE Berubicin Hydrochloride Tuparstobart More therapies…

    Learn about Your Condition

    Nicotine dependence Mast cell activation syndrome Leukaemia Angiosarcoma metastatic Malignant peritoneal neoplasm Overweight Atrial fibrillation Meniere's disease Hydrocele T-cell lymphoma Postoperative delirium Nodular melanoma Incisional hernia Mesothelioma Psoriatic arthropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Evangelismos S.A.

Evangelismos S.A.

Ipsiladou 45-47, Athens, 106 76, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Long-Term Safety of Isatuximab for Adults with Multiple Myeloma Benefiting from Isatuximab Therapy

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Buclizine Hydrochloride
    • Codeine Phosphate
    • Dexamethasone Base
    Czechia Finland France Greece Italy Spain +1

  • Study on Isatuximab, Carfilzomib, and Dexamethasone for Adults with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Buclizine Hydrochloride
    • Codeine Phosphate
    • Dexamethasone Sodium Phosphate Ph. Eur.
    Czechia Greece Portugal

  • Study on Fipaxalparant for Patients with Idiopathic Pulmonary Fibrosis

    Not recruiting

    2 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Fipaxalparant
    France Greece Italy The Netherlands Poland Spain

  • Study of daxdilimab injection for adults with moderate to severe discoid lupus erythematosus

    Not recruiting

    2 1
    Investigated Diseases:
    • Chronic cutaneous lupus erythematosus
    Investigated Drugs:
    • Daxdilimab
    Bulgaria Czechia Denmark France Germany Greece +1

  • Study on Long-term Safety of Seralutinib for Patients with Pulmonary Arterial Hypertension

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Seralutinib
    Austria Belgium Czechia Denmark France Germany +10

  • Study Comparing Ibrexafungerp and Fluconazole for Treating Candidemia or Invasive Candidiasis in Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Systemic candida
    Investigated Drugs:
    • Anidulafungin
    • Caspofungin Acetate
    • Clotrimazole
    Belgium Bulgaria France Germany Greece Italy +1

  • Study on the Tolerability and Efficacy of Asciminib vs. Nilotinib for Adults with Newly Diagnosed Philadelphia Chromosome Positive Chronic Myeloid Leukemia

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Asciminib Hydrochloride
    • Nilotinib
    Bulgaria Czechia France Germany Greece Hungary +4

  • Study Comparing Belantamab Mafodotin with Pomalidomide and Dexamethasone to Bortezomib with Pomalidomide and Dexamethasone for Patients with Relapsed/Refractory Multiple Myeloma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Belantamab Mafodotin
    • Bortezomib
    • Dexamethasone
    Czechia France Germany Greece Italy Poland +1

  • Study on Caplacizumab and Immunosuppressive Therapy for Adults with Immune-Mediated Thrombotic Thrombocytopenic Purpura

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Thrombotic thrombocytopenic purpura
    Investigated Drugs:
    • Caplacizumab
    Austria Belgium Czechia France Germany Greece +3

  • Study of Durbactagene Autoleucel and Drug Combination for Adults with Relapsed and Refractory Multiple Myeloma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Autologous T-Cells Encoding A Chimeric Antigen Receptor Targeting Human B Cell Maturation Antigen
    • Bendamustine
    • Cyclophosphamide
    France Germany Greece Italy Spain
Previous Page
1 … 9 10 11 12 13 14
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!